C : Cardiovascular system

C01: Cardiac therapy

• C01A : Cardiac glycosides

  • C01AA : Digitalis glycosides

    • Digoxin

  • C01AB : Scilla glycosides

  • C01AC : Strophanthus glycosides

  • C01AX : Other cardiac glycosides

• C01B : Antiarrhythmics, class I and III

  • C01BA : Antiarrhythmics, class Ia

  • C01BB : Antiarrhythmics, class Ib

    • Lidocaine

  • C01BC : Antiarrhythmics, class Ic

    • Flecainide

    • Propafenone

  • C01BD : Antiarrhythmics, class III

    • Amiodarone

    • Dronedarone

  • C01BG : Other antiarrhythmics, class I and III

• C01C : Cardiac stimulants excl. cardiac glycosides

  • C01CA : Adrenergic and dopaminergic agents

    • Adrenaline

    • Dobutamine

    • Dopamine

    • Ephedrine Hydrochloride

    • Ephedrine Sulfate

    • Midodrine

    • Norepinephrine

    • Phenylephrine

  • C01CE : Phosphodiesterase inhibitors

    • Milrinone

  • C01CX : Other cardiac stimulants

• C01D : Vasodilators used in cardiac diseases

  • C01DA : Organic nitrates

    • Glyceryl Trinitrate

    • Isosorbide Dinitrate

    • Isosorbide Mononitrate

  • C01DB : Quinolone vasodilators

  • C01DX : Other vasodilators used in cardiac diseases

    • Vericiguat

• C01E : Other cardiac preparations

  • C01EA : Prostaglandins

    • Alprostadil

  • C01EB : Other cardiac preparations

    • Adenosine

    • Ivabradine

    • Mavacamten

    • Ranolazine

    • Trimetazidine

  • C01EX : Other cardiac combination products

C02: Antihypertensives

• C02A : Antiadrenergic agents, centrally acting

  • C02AA : Rauwolfia alkaloids

  • C02AB : Methyldopa

    • Methyldopa

  • C02AC : Imidazoline receptor agonists

• C02B : Antiadrenergic agents, ganglion-blocking

  • C02BA : Sulfonium derivatives

  • C02BB : Secondary and tertiary amines

  • C02BC : Bisquaternary ammonium compounds

• C02C : Antiadrenergic agents, peripherally acting

  • C02CA : Alpha-adrenoreceptor antagonists

    • Doxazosin

    • Prazosin

  • C02CC : Guanidine derivatives

• C02D : Arteriolar smooth muscle, agents acting on

  • C02DA : Thiazide derivatives

  • C02DB : Hydrazinophthalazine derivatives

    • Hydralazine

  • C02DC : Pyrimidine derivatives

  • C02DD : Nitroferricyanide derivatives

  • C02DG : Guanidine derivatives

• C02K : Other antihypertensives

  • C02KA : Alkaloids, excl. rauwolfia

  • C02KB : Tyrosine hydroxylase inhibitors

  • C02KC : MAO inhibitors

  • C02KD : Serotonin antagonists

  • C02KN : Other antihypertensives

  • C02KX : Antihypertensives for pulmonary arterial hypertension

    • Ambrisentan

    • Bosentan

    • Macitentan

    • Riociguat

    • Sotatercept [Winrevair®]

• C02L : Antihypertensives and diuretics in combination

  • C02LA : Rauwolfia alkaloids and diuretics in combination

  • C02LB : Methyldopa and diuretics in combination

  • C02LC : Imidazoline receptor agonists in combination with diuretics

  • C02LE : Alpha-adrenoreceptor antagonists and diuretics

  • C02LF : Guanidine derivatives and diuretics

  • C02LG : Hydrazinophthalazine derivatives and diuretics

  • C02LK : Alkaloids, excl. rauwolfia, in combination with diuretics

  • C02LL : MAO inhibitors and diuretics

  • C02LN : Serotonin antagonists and diuretics

  • C02LX : Other antihypertensives and diuretics

• C02N : Combinations of antihypertensives in ATC-gr. C02

C03: Diuretics

• C03A : Low-ceiling diuretics, thiazides

  • C03AA : Thiazides, plain

    • Hydrochlorothiazide

  • C03AB : Thiazides and potassium in combination

  • C03AH : Thiazides, combinations with psycholeptics and/or analgesics

  • C03AX : Thiazides, combinations with other drugs

• C03B : Low-ceiling diuretics, excl. thiazides

  • C03BA : Sulfonamides, plain

    • Indapamide

  • C03BB : Sulfonamides and potassium in combination

  • C03BC : Mercurial diuretics

  • C03BD : Xanthine derivatives

  • C03BK : Sulfonamides, combinations with other drugs

  • C03BX : Other low-ceiling diuretics

• C03C : High-ceiling diuretics

  • C03CA : Sulfonamides, plain

    • Bumetanide

    • Furosemide

  • C03CB : Sulfonamides and potassium in combination

  • C03CC : Aryloxyacetic acid derivatives

  • C03CD : Pyrazolone derivatives

  • C03CX : Other high-ceiling diuretics

• C03D : Aldosterone antagonists and other potassium-sparing agents

  • C03DA : Aldosterone antagonists

    • Eplerenone

    • Finerenone

    • Spironolactone

  • C03DB : Other potassium-sparing agents

• C03E : Diuretics and potassium-sparing agents in combination

  • C03EA : Low-ceiling diuretics and potassium-sparing agents

    • Amiloride + Hydrochlorothiazide

    • Triamterene + Hydrochlorothiazide

  • C03EB : High-ceiling diuretics and potassium-sparing agents

• C03X : Other diuretics

  • C03XA : Vasopressin antagonists

    • Tolvaptan

C04: Peripheral vasodilators

• C04A : Peripheral vasodilators

  • C04AA : 2-amino-1-phenylethanol derivatives

  • C04AB : Imidazoline derivatives

  • C04AC : Nicotinic acid and derivatives

  • C04AD : Purine derivatives

    • Pentoxifylline

  • C04AE : Ergot alkaloids

  • C04AF : Enzymes

  • C04AX : Other peripheral vasodilators

C05: Vasoprotectives

• C05A : Agents for treatment of hemorrhoids and anal fissures for topical use

  • C05AA : Corticosteroids

    • Aesculin + Cinchocaine + Framycetin + Hydrocortisone

  • C05AB : Antibiotics

  • C05AD : Local anesthetics

    • Procaine

  • C05AE : Muscle relaxants

    • Glyceryl Trinitrate

  • C05AX : Other agents for treatment of hemorrhoids and anal fissures for topical use

• C05B : Antivaricose therapy

  • C05BA : Heparins or heparinoids for topical use

    • Mucopolysaccharide Polysulphate

  • C05BB : Sclerosing agents for local injection

    • Phenol (in Almond Oil)

    • Polidocanol

  • C05BX : Other sclerosing agents

• C05C : Capillary stabilizing agents

  • C05CA : Bioflavonoids

    • Diosmin + Hesperidin

  • C05CX : Other capillary stabilizing agents

• C05X : Other Vasoprotectives

  • C05XX : Other Vasoprotectives

C07: Beta blocking agents

• C07A : Beta blocking agents

  • C07AA : Beta blocking agents, non-selective

    • Propranolol

    • Sotalol

  • C07AB : Beta blocking agents, selective

    • Acebutolol

    • Atenolol

    • Betaxolol

    • Bisoprolol

    • Metoprolol

    • Nebivolol

  • C07AG : Alpha and beta blocking agents

    • Carvedilol

    • Labetalol

• C07B : Beta blocking agents and thiazides

  • C07BA : Beta blocking agents, non-selective, and thiazides

  • C07BB : Beta blocking agents, selective, and thiazides

  • C07BG : Alpha and beta blocking agents and thiazides

• C07C : Beta blocking agents and other diuretics

  • C07CA : Beta blocking agents, non-selective, and other diuretics

  • C07CB : Beta blocking agents, selective, and other diuretics

  • C07CG : Alpha and beta blocking agents and other diuretics

• C07D : Beta blocking agents, thiazides and other diuretics

  • C07DA : Beta blocking agents, non-selective, thiazides and other diuretics

  • C07DB : Beta blocking agents, selective, thiazides and other diuretics

• C07E : Beta blocking agents and vasodilators

  • C07EA : Beta blocking agents, non-selective, and vasodilators

  • C07EB : Beta blocking agents, selective, and vasodilators

• C07F : Beta blocking agents, other combinations

  • C07FB : Beta blocking agents and calcium channel blockers

    • Amlodipine + Bisoprolol

    • Atenolol + Nifedipine

  • C07FX : Beta blocking agents, other combinations

    • Carvedilol + Ivabradine

C08: Calcium channel blockers

• C08C : Selective calcium channel blockers with mainly vascular effects

  • C08CA : Dihydropyridine derivatives

    • Amlodipine

    • Felodipine

    • Lacidipine

    • Levamlodipine

    • Nifedipine

    • Nimodipine

  • CO8CX : Other selective calcium channel blockers with mainly vascular effects

• C08D : Selective calcium channel blockers with direct cardiac effects

  • C08DA : Phenylalkylamine derivatives

    • Verapamil

  • C08DB : Benzothiazepine derivatives

    • Diltiazem

• C08E : Non-selective calcium channel blockers

  • C08EA : Phenylalkylamine derivatives

  • C08EX : Other non-selective calcium channel blockers

• C08G : Calcium channel blockers and diuretics

  • C08GA : Calcium channel blockers and diuretics

    • Amlodipine + Indapamide

C09: Agents acting on the renin-angiotensin system

• C09A : ACE inhibitors, plain

  • C09AA : ACE inhibitors, plain

    • Captopril

    • Enalapril

    • Imidapril

    • Lisinopril

    • Perindopril Arginine

    • Perindopril Erbumine

    • Ramipril

• C09B : ACE inhibitors, combinations

  • C09BA : ACE inhibitors and diuretics

    • Enalapril + Hydrochlorothiazide

    • Indapamide + Perindopril Arginine

  • C09BB : ACE inhibitors and calcium channel blockers

    • Amlodipine + Perindopril Arginine

    • Amlodipine + Perindopril Erbumine

  • C09BX : ACE inhibitors, other combinations

    • Amlodipine + Indapamide + Perindopril Arginine

    • Bisoprolol + Perindopril Arginine

• C09C : Angiotensin II receptor blockers (ARBs), plain

  • C09CA : Angiotensin II receptor blockers (ARBs), plain

    • Candesartan Cilexetil

    • Eprosartan

    • Fimasartan

    • Irbesartan

    • Losartan

    • Olmesartan Medoxomil

    • Telmisartan

    • Valsartan

• C09D : Angiotensin II Receptor Blockers (ARBs), combinations

  • C09DA : Angiotensin II receptor blockers (ARBs) and diuretics

    • Candesartan Cilexetil + Hydrochlorothiazide

    • Hydrochlorothiazide + Irbesartan

    • Hydrochlorothiazide + Telmisartan

    • Hydrochlorothiazide + Valsartan

    • Losartan + Hydrochlorothiazide

  • C09DB : Angiotensin II receptor blockers (ARBs) and calcium channel blockers

    • Amlodipine + Irbesartan

    • Amlodipine + Losartan

    • Amlodipine + Olmesartan Medoxomil

    • Amlodipine + Telmisartan

    • Amlodipine + Valsartan

  • C09DX : Angiotensin II receptor blockers (ARBs), other combinations

    • Amlodipine + Hydrochlorothiazide + Valsartan

    • Sacubitril + Valsartan

• C09X : Other agents acting on the renin-angiotensin system

  • C09XA : Renin-inhibitors

  • C09XX : Other agents acting on the renin-angiotensin system

C10: Lipid modifying agents

• C10A : Lipid modifying agents, plain

  • C10AA : HMG CoA reductase inhibitors

    • Atorvastatin

    • Lovastatin

    • Pitavastatin

    • Pravastatin

    • Rosuvastatin

    • Simvastatin

  • C10AB : Fibrates

    • Bezafibrate

    • Choline Fenofibrate

    • Fenofibrate

    • Gemfibrozil

    • Pemafibrate

  • C10AC : Bile acid sequestrants

    • Colestyramine

  • C10AD : Nicotinic acid and derivatives

  • C10AX : Other lipid modifying agents

    • Alirocumab [Praluent]

    • Evolocumab [Repatha]

    • Ezetimibe

    • Inclisiran

    • Omega-3-Triglycerides

• C10B : Lipid modifying agents, combinations

  • C10BA : Combinations of various lipid modifying agents

    • Atorvastatin + Ezetimibe

    • Ezetimibe + Rosuvastatin

    • Ezetimibe + Simvastatin

    • Fenofibrate + Pravastatin

    • Fenofibrate + Simvastatin

  • C10BX : Lipid modifying agents in combination with other drugs

    • Amlodipine + Atorvastatin

    • Amlodipine + Atorvastatin + Perindopril Arginine

    • Aspirin + Atorvastatin + Ramipril